SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jenburkt Pharma - Quaterly Results

29 Oct 2025 Evaluate
A fair growth of 10.53% in the revenue at Rs. 455.58 millions was reported in the September 2025 quarter as compared to Rs. 412.16 millions during year-ago period.A humble growth in net profit of 5.84% reported in the quarter ended September 2025 to Rs. 101.63  millions from Rs. 96.02 millions.Operating profit surged to 151.83 millions from the corresponding previous quarter of 132.79 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 455.58 412.16 10.53 810.85 737.52 9.94 1516.92 1419.66 6.85
Other Income 20.79 18.53 12.20 41.36 32.59 26.91 67.21 46.67 44.01
PBIDT 151.83 132.79 14.34 261.98 239.73 9.28 471.13 377.85 24.69
Interest 1.07 1.16 -7.76 2.17 2.31 -6.06 4.53 2.71 67.16
PBDT 150.76 131.63 14.53 259.81 237.42 9.43 466.60 375.14 24.38
Depreciation 7.44 6.39 16.43 14.66 11.58 26.60 27.28 23.40 16.58
PBT 143.32 125.24 14.44 245.15 225.84 8.55 439.32 351.74 24.90
TAX 41.69 29.22 42.68 65.59 55.67 17.82 118.72 91.98 29.07
Deferred Tax 1.69 -0.78 -316.67 5.59 0.67 734.33 -2.06 -5.21 -60.46
PAT 101.63 96.02 5.84 179.56 170.17 5.52 320.60 259.76 23.42
Equity 44.13 44.13 0.00 44.13 44.13 0.00 44.13 44.13 0.00
PBIDTM(%) 33.33 32.22 3.44 32.31 32.50 -0.60 31.06 26.62 16.69

Jenburkt Pharma Share Price

1050.40 24.80 (2.42%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×